Qiao Li
- Cancer Research top 2%
- Breast Cancer Treatment Studies 27
- Cancer Genomics and Diagnostics 11
- Cancer-related molecular mechanisms research 9
- Oncology top 5%
- Cancer Treatment and Pharmacology 33
- HER2/EGFR in Cancer Research 32
-
- Advanced Breast Cancer Therapies 27
- Lung Cancer Treatments and Mutations 12
-
- Monoclonal and Polyclonal Antibodies Research 11
- Genetics top 10%
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qiao Li
138 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 778
- Oncology 966
- Pulmonary and Respiratory Medicine 542
- Radiology, Nuclear Medicine and Imaging 286
- Genetics 110
Countries citing papers authored by Qiao Li
This map shows the geographic impact of Qiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiao Li more than expected).
Fields of papers citing papers by Qiao Li
This network shows the impact of papers produced by Qiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiao Li. The network helps show where Qiao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 18 | |
| 14 | 2020 | 29 | |
| 15 | 2020 | 9 | |
| 16 | 2019 | 61 | |
| 17 | 2018 | 27 | |
| 18 | 2018 | 5 | |
| 19 | 2018 | 16 | |
| 20 | 2016 | 1 |
About Qiao Li
Qiao Li is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 152 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (33 papers), HER2/EGFR in Cancer Research (32 papers), Advanced Breast Cancer Therapies (27 papers), Breast Cancer Treatment Studies (27 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (778 citations), Oncology (966 citations) and Pulmonary and Respiratory Medicine (542 citations). Qiao Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fei Ma, Binghe Xu, Shanshan Chen, Pin Zhang, Ruigang Cai, Yang Luo, Ying Fan, Jiayu Wang, Peng Yuan and Xiuwen Guan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.